Profund Advisors LLC Capricor Therapeutics, Inc. Transaction History

Profund Advisors LLC

  • $2.97 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025
SELL
$6.34 - $14.23 $43,536 - $97,717
-6,867 Reduced 40.14%
10,241 $101,000
Q1 2025

May 08, 2025
SELL
$9.49 - $16.11 $65,471 - $111,142
-6,899 Reduced 28.74%
17,108 $162,000
Q4 2024

Feb 13, 2025
BUY
$12.9 - $21.99 $309,690 - $527,913
24,007 New
24,007 $332,000

Others Institutions Holding CAPR

# of Institutions
141
Shares Held
13.3M
Call Options Held
4M
Put Options Held
2.76M
View Full List

About CAPRICOR THERAPEUTICS, INC.

CAPR Quotes by TradingView
  • Ticker CAPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,346,200
  • Market Cap $137M
  • Description
  • Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...
More about CAPR
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email